As a Principal at Remiges Ventures, Kazuhiko leverages over 20 years of experience in drug discovery, licensing, and R&D from roles at Boehringer Ingelheim and Mochida Pharmaceutical. He holds a Ph. D. from Nagoya City University and focuses on early-stage life science investments.
His specific investment and research expertise lies in complex therapeutic areas, including the central nervous system (CNS), pain, and immunology.
Kazuhiko NONOMURA
Principal at Remiges Ventures
Japan
Overview
Topics They Care About
Biotech Investing
As a Principal at a venture capital firm, he is actively involved in evaluating and investing in early-stage life science and biotechnology companies.
Pharmaceutical R&D
He has an extensive background with over two decades of experience in drug discovery research at companies like Mochida Pharmaceutical and RaQualia Pharma.
Life Science Partnering
Actively attends major industry events, such as BIO-Europe, to meet with potential partners and collaborators in the life sciences sector.
Media Appearances
Kazuhiko has no verified media appearances
Work History
1-2020
Principal at Remiges Ventures
11-2017 - 12-2019
Manager, RBB and R&D Liason Dept. at Boehringer Ingelheim
1-2017 - 10-2017
Manager, Licensing at Mochida Pharmaceutical Co., Ltd
4-2012 - 12-2016
Manager, Discovery Research at Mochida Pharmaceutical Co., Ltd
8-2008 - 3-2012
Principal Scientist at RaQualia Pharma Inc.
4-1999 - 7-2008
Scientist at Novartis Pharma K.k.
Education
2007 - 2011
博士 from 名古屋市立大学
1993 - 1999
修士 from Kyoto University
More Information
Social Presence :
Prographics :
Exp : 26
Location : Japan
Job Level : Senior
Designation : Principal at Remiges Ventures
